CVS Health Corporation (CVS) Receives ‘Analyst’ Rating

CVS Health Corporation (CVS) : The consensus on CVS Health Corporation (CVS) based on 20 analyst recommendation on the company stock is 1.45, which is interpreted as a Strong Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 15 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 1 analyst believes that the stock is a Buy, which can produce decent returns in the future. 4 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating.

CVS Health Corporation (CVS) : 21 Wall Street analysts covering CVS Health Corporation (CVS) believe that the average level the stock could reach for the short term is $111.88. The maximum price target given is $123 and the minimum target for short term is around $90, hence the standard deviation is calculated at $7.5.


Also, Equity analysts at the Brokerage firm Citigroup maintains its rating on CVS Health Corporation (NYSE:CVS). The rating major has initiated the coverage with neutral rating on the shares. The Analysts at Citigroup lowers the price target from $115 per share to $108 per share. The rating by the firm was issued on August 8, 2016.

CVS Health Corporation (NYSE:CVS): After opening at $89.14, the stock dipped to an intraday low of $88.1 on Thursday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $90.22 and the buying power remained strong till the end. The stock closed at $90.15 for the day, a gain of 0.79% for the day session. The total traded volume was 7,487,204. The stocks close on the previous trading day was $89.44.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise, including over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, photo finishing, seasonal merchandise and greeting cards through the Companys retail stores, online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company, through its wholly owned subsidiary, Omnicare, Inc., provides pharmacy services to long term care facilities.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.